STE PE Ratio & Valuation, Is STE Overvalued

Historical Valuation

STERIS plc (STE) is now in the Undervalued zone, suggesting that its current forward PE ratio of 23.51 is considered Undervalued compared with the five-year average of 24.44. The fair price of STERIS plc (STE) is between 255.58 to 292.31 according to relative valuation method. Compared to the current price of 222.08 USD , STERIS plc By Undervalued By 13.11%.

Relative Value

Fair Zone

255.58-292.31

Current Price：222.08

13.11%

Undervalued

P/E

EV/EBITDA

EV/EBIT

P/S

P/OCF

P/FCF

Trailing

Forward

Unlock 5-Year Valuation Change

Is STERIS plc (STE) at a historical peak or a rare bargain? Access the full 5-year trend to find out.

Unlock Now

STERIS plc (STE) has a current Price-to-Book (P/B) ratio of 3.50. Compared to its 3-year average P/B ratio of 3.43, the current P/B ratio is approximately 1.97% higher. Relative to its 5-year average P/B ratio of 3.45, the current P/B ratio is about 1.48% higher. STERIS plc (STE) has a Forward Free Cash Flow (FCF) yield of approximately 3.92%. Compared to its 3-year average FCF yield of 2.92%, the current FCF yield is approximately 34.10% lower. Relative to its 5-year average FCF yield of 2.56%, the current FCF yield is about 52.99% lower.

Competitors Valuation Multiple

AI Analysis

The average P/S ratio for STE competitors is 4.58, providing a benchmark for relative valuation. STERIS plc Corp (STE.N) exhibits a P/S ratio of 4.02, which is -12.26% above the industry average. Given its robust revenue growth of 9.17%, this premium appears unsustainable.

P/E

P/S

EV/EBITDA

EV/EBIT

Earnings Growth

Market Cap

Performance Decomposition

AI Analysis

Market capitalization of STE increased by 0.00% over the past 1 year(s). The primary factor behind the change was an decrease in Unknown from 0.00 to 0.00.

The secondary factor is the Unknown, contributed 0.00% to the performance.

Overall, the performance of STE in the past 1 year(s) is driven by Unknown.

People Also Watch

Frequently Asked Questions

Is STE currently overvalued or undervalued?

What is STERIS plc (STE) fair value?

STE's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. The fair price of STERIS plc (STE) is between 255.58 to 292.31 according to relative valuation method.

How does STE's valuation metrics compare to the industry average?

The average P/S ratio for STE's competitors is 4.58, providing a benchmark for relative valuation. STERIS plc Corp (STE) exhibits a P/S ratio of 4.02, which is -12.26% above the industry average. Given its robust revenue growth of 9.17%, this premium appears unsustainable.

What is the current P/B ratio for STERIS plc (STE) as of Mar 10 2026?

As of Mar 10 2026, STERIS plc (STE) has a P/B ratio of 3.50. This indicates that the market values STE at 3.50 times its book value.

What is the current FCF Yield for STERIS plc (STE) as of Mar 10 2026?

As of Mar 10 2026, STERIS plc (STE) has a FCF Yield of 3.92%. This means that for every dollar of STERIS plc's market capitalization, the company generates 3.92 cents in free cash flow.

What is the current Forward P/E ratio for STERIS plc (STE) as of Mar 10 2026?

As of Mar 10 2026, STERIS plc (STE) has a Forward P/E ratio of 23.51. This means the market is willing to pay $23.51 for every dollar of STERIS plc's expected earnings over the next 12 months.

What is the current Forward P/S ratio for STERIS plc (STE) as of Mar 10 2026?

As of Mar 10 2026, STERIS plc (STE) has a Forward P/S ratio of 4.02. This means the market is valuing STE at $4.02 for every dollar of expected revenue over the next 12 months.

STE Valuation